生化复发
医学
前列腺切除术
危险系数
前列腺特异性抗原
前列腺癌
手术切缘
回顾性队列研究
比例危险模型
外科
泌尿科
前列腺
内科学
癌症
置信区间
作者
Takahito Negishi,Keita Kuroiwa,Yozo Hori,Toshihisa Tomoda,Hiroshi Uchino,Noriaki Tokuda,Nobuki Furubayashi,Kei Nagase,Hidenori Iwai,Motonobu Nakamura
出处
期刊:Japanese Journal of Clinical Oncology
[Oxford University Press]
日期:2016-12-09
卷期号:47 (3): 233-238
被引量:13
摘要
To assess the characteristics of biochemical recurrence in the late period (>5 years after radical prostatectomy) and the differences in the predictors of biochemical recurrence in different periods, we conducted a multicenter retrospective study.We reviewed 478 men who underwent radical prostatectomy for clinically localized prostate cancer. All of the patients were followed up for at least 5 years. The cohort was then divided into three groups; no recurrence group, recurrence <5 years after surgery group and recurrence ≥5 years after surgery group. The background characteristics of each group were compared using the χ2 test. A Cox multivariate regression analysis was performed to determine the predictors of biochemical recurrence in each period.Biochemical recurrence occurred in 135 men. In 113 (84%) of the patients, biochemical recurrence occurred at <5 years after surgery; in 22 (16%), it occurred at ≥5 years after surgery. The proportion of men with a low preoperative prostate-specific antigen level was significantly larger in the latter group (P = 0.0023). A preoperative prostate-specific antigen level and a positive surgical margin were significant predictors of biochemical recurrence at <5 years after surgery (hazard ratio: 1.03 and 3.20). A positive surgical margin was also a significant predictor of biochemical recurrence at ≥5 years after surgery (hazard ratio: 3.03); however, a high preoperative prostate-specific antigen level was not.Biochemical recurrence occurred at ≥5 years after surgery in 16% of the patients. A positive surgical margin predicted biochemical recurrence in both the early and late periods.
科研通智能强力驱动
Strongly Powered by AbleSci AI